By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 Speen Street, Suite 306

Framingham  Massachusetts   01701  U.S.A.
Phone: 508-861-7709 Fax: n/a


Key Statistics

Ownership: Private

Web Site: Alzheon


Company News
Alzheon To Present Novel Molecular Mechanism Of Action And Long Term Clinical Efficacy Data For Lead Candidate ALZ-801 At The Alzheimer’s Association International Conference 6/22/2017 8:44:02 AM
Alzheon Publishes New Analyses Showing Clinical Benefit Of Tramiprosate In APOE4/4 Homozygous Patients With Mild Alzheimer’s Disease; Clinical Effects Suggest Disease Modification And Align With Beta Amyloid Oligomer Formation 6/22/2017 8:38:24 AM
Alzheon Scientists Discover Novel Therapeutic Mechanism Of Inhibition Of Formation Of Toxic Beta Amyloid Oligomers, Key Driver Of Alzheimer’s Disease Pathogenesis 4/25/2017 6:47:15 AM
Alzheon Presents Data To Support Selection Of Patients With Mild Alzheimer’s Disease For Pivotal Study Of ALZ-801 Using Precision Medicine Approach 3/30/2017 8:18:18 AM
Alzheon To Present New Clinical Data And Analyses For ALZ-801 And Its Active Molecule Tramiprosate At The 13th International Conference On Alzheimer’s And Parkinson’s Diseases 2/13/2017 12:00:03 PM
Alzheon Appoints Neil Flanzraich, JD, As Chief Business Officer 2/13/2017 7:09:39 AM
Alzheon Appoints Nobel Laureate Stanley B. Prusiner, MD, As Chair Of Scientific Advisory Board 1/4/2017 10:03:26 AM
Alzheon Presents Analyses From Phase III Clinical Studies Showing Largest Clinical Effects Of Tramiprosate, The Active Molecule Of ALZ-801, In APOE4/4 Homozygous Patients With Mild Alzheimer’s Disease 12/9/2016 6:54:13 AM
Alzheon Publishes New Analyses From Phase III Studies Showing Clinical Benefit Of Tramiprosate In Alzheimer’s Patients Who Are Carriers Of APOE4, The Major Genetic Risk Factor In Up To 65 Percent Of Alzheimer’s Patients 10/24/2016 10:56:07 AM
Alzheon To Present At Upcoming Asian Healthcare And Scientific Conferences 10/4/2016 11:31:00 AM